Drugs / Recombinant Human DNase
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00179998 Comparator | Jan 2005 → Oct 2008 | cystic fibrosis | Nationwide Children's Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant Human DNase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00179998 ↗ |
| Route | Inhaled | “2.5 mg in 3 ml diluent delivered by nebulization” NCT00179998 ↗ |